ALGINOR BIOREFINERY AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: KR
Kjetil Thormodsen Rein1979
Chairman of the board: KR
Kjetil Thormodsen Rein1979
Years since formation: 6 years; since Jan 10, 2018
Type: Limited company
VAT registered: Yes
Number of employees: 14

Ownership

Number of shares and share classes: 500,000; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Annual total result 2023: -1,398,516; NOK
Total equity 2023: 73,556,533; NOK

Last update: Dec 12, 2024

Management

Management / administration

Name	Role	Shares
KR Kjetil Thormodsen Rein 1979	Managing Director/CEO	-

Board

Name	Role	Shares
HF Haakon Simonsen Farstadvoll 1992	Board Member	-
KR Kjetil Thormodsen Rein 1979	Chairman	-
LA Lene Kili Apeland 1988	Board Member	-

Others

Name	Role	Shares
K KPMG AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
JH Jakob Hatteland 1951	-	6.79 % indirectly
TT Thorleif Thormodsen 1960	-	4.37 % indirectly
ØH Øystein Hatteland 1992	-	1.7 % indirectly
BA Bjørn Mathias Apeland 1953	-	1.21 % indirectly
SE Stian Egeland-Helgøy 1973	-	1.19 % indirectly
TM Trine Must 1971	-	1.12 % indirectly
EC Erik Christian Must 1973	-	1.12 % indirectly

Last update: Mar 7, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
A ALGINOR ASA	Ordinary shares	500,000	100 %

Last update: May 24, 2024

Group structure

ALGINOR ASA
Total operating income 2023: NOK 0
Operating profit 2023: NOK -26,167,930
Employees: 35

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	0	195,296	0
Annual Total Result	-1,398,516	429,738	-277,272
Total assets	83,733,305	75,017,550	74,525,312
Total liabilities	10,176,771	62,500	0
Total equity	73,556,533	74,955,050	74,525,312

P&L

Year	2023	2022	2021
Total operating income	0	195,296	0
Total operating costs	2,590,582	395,653	277,272
Operating result	-2,590,582	-200,357	-277,272
Financial income/costs	1,192,066	630,095	0
Profit before tax	-1,398,516	429,738	-277,272
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	-1,398,516	429,738	-277,272

Balance overview

Year	2023	2022	2021
Total fixed assets	42,112,632	11,446,828	0
Total current assets	41,620,672	63,570,722	74,525,312
Total assets	83,733,305	75,017,550	74,525,312
Short term debt	9,879,120	62,500	0
Long term debt	297,651	0	0
Total liabilities	10,176,771	62,500	0
Contributed capital	74,525,312	74,525,312	74,525,312
Retained earnings	-968,778	429,738	0
Total equity	73,556,533	74,955,050	74,525,312
Total equity and liabilities	83,733,305	75,017,550	74,525,312

ALGINOR BIOREFINERY AS920 217 222